Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial

  1. Weisz, G.
  2. Généreux, P.
  3. Iñiguez, A.
  4. Zurakowski, A.
  5. Shechter, M.
  6. Alexander, K.P.
  7. Dressler, O.
  8. Osmukhina, A.
  9. James, S.
  10. Ohman, E.M.
  11. Ben-Yehuda, O.
  12. Farzaneh-Far, R.
  13. Stone, G.W.
Journal:
The Lancet

ISSN: 1474-547X 0140-6736

Year of publication: 2016

Volume: 387

Issue: 10014

Pages: 136-145

Type: Article

DOI: 10.1016/S0140-6736(15)00459-6 GOOGLE SCHOLAR

Sustainable development goals